Dr. Kucuk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5665 Peachtree Dunwoody Rd
Atlanta, GA 30342Phone+1 678-843-7001Fax+1 404-851-7339
Summary
- Dr. Omer Kucuk is an oncologist in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital, Emory University Hospital Midtown, Grady Memorial Hospital, and Emory Saint Joseph's Hospital of Atlanta. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 42 years. He specializes in genitourinary oncology and is experienced in prostate cancer, urinary bladder cancer, kidney cancer and testis cancer.
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1980 - 1981
- Presence Saint Francis HospitalFellowship, Hematology and Medical Oncology, 1979 - 1980
- Presence Saint Francis HospitalFellowship, Hematology, 1978 - 1979
- Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1975 - 1978
- Hacettepe University FOMClass of 1975
Certifications & Licensure
- HI State Medical License 1991 - 2026
- GA State Medical License 2008 - 2025
- MI State Medical License 1977 - 2024
- IL State Medical License 1977 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Atlanta Magazine: Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth Start of enrollment: 1997 Dec 01
- Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Start of enrollment: 2000 Dec 18
- Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia Start of enrollment: 2003 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsLong-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Canc...John J Coen, Joseph P Rodgers, Philip J Saylor, Cheryl T Lee, Chin-Lee Wu
International Journal of Radiation Oncology, Biology, Physics. 2025-01-01 - 1 citationsPD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.Dylan J Martini, Katherine B Case, Derrik Gratz, Kathryn Pellegrini, Elizabeth Beagle
Cancer. 2024-11-01 - The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.Gregory Palmateer, Edouard H Nicaise, Jatin Gandhi, Taylor Goodstein, Michelle Sheng
Urology Case Reports. 2024-11-01
Journal Articles
- The Addition of Chemotherapy in the Definitive Management of High Risk Prostate CancerBradley C Carthon, Mehmet A Bilen, Omer Kucuk, Urologic Oncology
Authored Content
- Retraction Notice to: Sensitization of Squamous Cell Carcinoma to Cisplatin Induced Killing by Natural AgentsMarch 2018
Press Mentions
- Angelina Jolie's Doctor Urges Women to UP Their Soya Intake, Devour More of One Type of Fruit and Ditch Anti-Bacterial Soap as She Shares Her Top 10 Tips to Prevent Breast CancerOctober 6th, 2017
- Soy Products Are GOOD for Fighting Breast Cancer, Study Finds - After Confusing One-off Research Said the OppositeMarch 8th, 2017
- Winship Expert Touts Soy Use in the Journal CancerMarch 6th, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: